Business Medical Dialogues

RSS Feed URL: http://business.medicaldialogues.in/feed/
Category: Health | Total Views: 31

Latest entries from this feed

Johnson multiple myeloma drug succeeds in first-line combination study

Posted on 23 November 2017 | 4:30 am by Ruby Khatun

Johnson and Johnson’s blockbuster multiple myeloma drug¬†Darzalex¬†when added to a standard therapy regimen reduced the risk of disease progression or death by 50 percent compared with the standard therapy alone in patients not previously treated for the blood cancer, according to data released on Tuesday. The data could lead to approval of the Darzalex combination

The post Johnson multiple myeloma drug succeeds in first-line combination study appeared first on Business | Medical Dialogues.



Related products